6505--770-25-1-801-0019 -National CMOP BUDESONIDE -(VA-25-00010963)
ID: 36C77025Q0044Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/d3e66543b0fd4975b458c3d898e0397e/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting proposals for the procurement of Budesonide 0.5MG/2ML inhalation suspension through the National CMOP program. Vendors are required to submit a signed SF1449 solicitation cover page, a completed quote spreadsheet, evidence of a valid state wholesale distributor license, and a Trade Agreement Act certificate, with all submissions due by November 8, 2024. This pharmaceutical is critical for the treatment of respiratory conditions among veterans, and all products must comply with stringent regulatory standards, including bar-coding and adherence to the Drug Supply Chain Security Act. Interested vendors can contact Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov for further details.

    Point(s) of Contact
    Kelley CunninghamContract Specialist
    kelley.cunningham@va.gov
    Files
    Title
    Posted
    36C77025Q0044_1.docx
    The document outlines a Request for Proposal (RFP) from the Department of Veterans Affairs (VA) for the procurement of Budesonide 0.5MG/2ML inhalation suspension. Key components include the delivery schedule to various VA Consolidated Mail Outpatient Pharmacy (CMOP) locations, administrative and contract clauses, and specific requirements for pharmaceutical compliance. The contract emphasizes the need for products to be bar-coded according to GS1 or HIBCC standards and requires vendors to provide firm commitments regarding product availability and pricing shortly before order fulfillment. Additional stipulations include adherence to the Drug Supply Chain Security Act, with strict guidelines on shipping processes, invoicing, and regulatory compliance. The RFP sets forth pricing schedules, quantity requirements, and terms for payment processing, detailing the responsibilities of both the contractor and the government. The document serves as a comprehensive framework for ensuring quality and accountability in the procurement of essential medications, reflecting the VA's commitment to compliance with federal regulations and service to veterans.
    36C77025Q0044.docx
    The Department of Veterans Affairs (VA) plans to issue a presolicitation notice for the procurement of Budesonide inhalation suspension, intended for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The solicitation number is 36C77025Q0044, and the estimated issuance date is November 1, 2024, with responses due by November 8, 2024. The requirements include quantities for various CMOP locations, with a total of 17,200 units to be delivered within ten days after order receipt. This procurement falls under the full and open competition set-aside category, relating to product service codes for drugs and biologicals. Offerors must provide a state wholesale distributor license and must comply with the Drug Supply Chain Security Act (DSCSA). Notably, bids from the manufacturer Nephron are prohibited. All submissions must be made via email to the designated contract specialist. This presolicitation reflects the VA's commitment to ensuring an efficient supply chain for critical medications while complying with necessary regulations.
    S02_Pricing Schedule_Q0044.xlsx
    The document outlines a Request for Quote (RFQ) from the VA pertaining to the purchase of pharmaceuticals through the CMOP program. It details the submission requirements for vendors, including a signed SF1449 solicitation cover page, an completed quote spreadsheet, evidence of a valid state wholesale distributor license, and a Trade Agreement Act certificate. The closing date for submissions is set for November 8, 2024, with a stipulated delivery time of 10 days after receipt of the order. Vendors must provide quotes that comply with specified product standards, particularly noting that proposals including Nephron products are not acceptable. Furthermore, all pharmaceuticals must have at least a one-year expiration date upon delivery. The RFQ includes listed items with corresponding National Drug Codes (NDC), quantities, and requires vendors to supply comments if alternative counts are being proposed. The RFQ seeks compliance for pharmaceuticals across several CMOP facilities, focusing on efficient procurement and adherence to regulatory standards to support the VA's operations.
    Similar Opportunities
    6505--Betamethasone RFP
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the supply of Betamethasone Dipropionate Cream, a pharmaceutical product essential for the healthcare of veterans. Offerors are required to submit competitive pricing for a base year and four option years, including a mandatory 0.5% Cost Recovery Fee, while ensuring compliance with the Drug Supply Chain Security Act and Good Manufacturing Practices. This contract is vital for maintaining a consistent supply of medications through the VA and Department of Defense's Prime Vendor Programs, emphasizing the government's commitment to providing quality healthcare to service members. Interested vendors should contact Contract Specialist Amber Zavala at amber.zavala@va.gov for further details regarding the solicitation.
    6505--770-25-1-801-0021 -National CMOP DORZOLAMIDE/TIMOLOL -VA-25-00011267)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to procure DORZOLAMIDE/TIMOLOL ophthalmic solution for its Centralized Mail Order Pharmacy (CMOP) facilities. This procurement involves acquiring quantities ranging from 2,880 to 9,600 units of 10ML packaging, with a focus on ensuring compliance with the Drug Supply Chain Security Act and other regulatory standards. The pharmaceutical products are critical for providing necessary medical care to veterans, reflecting the VA's commitment to delivering high-quality healthcare solutions. Interested vendors must submit their quotations by November 12, 2024, following the release of the solicitation on November 4, 2024, and can direct inquiries to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0052 770-25-1-801-0071 -National CMOP FERROUS SULFATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking bids for an emergency procurement of Ferrous Sulfate 324MG EC Tablets, specifically packaged in bottles of 100, to be delivered to various Consolidated Mail Outpatient Pharmacy (CMOP) facilities across the United States. The procurement requires a total of seven different quantities ranging from 1,200 to 9,600 units, with a delivery timeframe of 10 days after receipt of order (ARO). This initiative is crucial for maintaining a reliable pharmaceutical supply chain to support the healthcare needs of veterans. Interested vendors must submit their proposals by November 6, 2024, at 9:00 AM CST, including a signed SF1449 cover page, a price schedule in Excel format, a state wholesale distributor license, and a completed Trade Agreements Certificate, with the estimated award date set for November 12, 2024. For further inquiries, vendors can contact Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov or (913) 684-0134.
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--760_Pharmaceuticals_VA CMOP Leavenworth_36C77025Q0050 760-25-1-050-0022 - Leavenworth CMOP AMLODIPINE (VA-25-00014183)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply various pharmaceuticals for delivery to the Consolidated Mail Outpatient Pharmacy (CMOP) facility in Leavenworth, Kansas, under solicitation number 36C77025Q0050. The procurement includes a range of medications, with specific quantities and packaging requirements, emphasizing compliance with the Drug Supply Chain Security Act and the Buy American statute. This initiative is crucial for ensuring a reliable supply of essential medications for veteran care services. Interested vendors must submit their quotes, including a signed SF1449 cover page, a price schedule in Excel format, and a state wholesale distributor license, by November 6, 2024, with an anticipated award date of November 13, 2024. For further inquiries, vendors can contact Jeffrey Blackard at Jeffrey.Blackard@va.gov or (913) 684-0142.
    6505--Norethindrone 5mg Tablet (VA-25-00005551)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the supply of Norethindrone Acetate Tablets under Request for Proposal (RFP) 36E79724R0027. The procurement aims to establish contracts for the pharmaceutical product, with specific requirements regarding pricing for a base year and four option years, compliance with packaging standards, and adherence to the Drug Supply Chain Security Act (DSCSA) regulations. This medication is essential for various health treatments within the VA system, ensuring that veterans receive necessary pharmaceutical care. Interested contractors must submit their proposals by November 15, 2024, at 2:30 PM Central Standard Time, to the designated email addresses provided in the solicitation documents. For further inquiries, potential bidders can contact Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6505--763-24-3-021-1011 -Lancaster CMOP CLOMIPHENE CITRATE -(VA-24-00076661)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Clomiphene Citrate 50mg tablets for delivery to the Lancaster Consolidated Mail Outpatient Pharmacy (CMOP) facility in Texas. The procurement involves a requirement for 480 units of the specified pharmaceutical, with a focus on compliance with the Drug Supply Chain Security Act and other federal regulations. This opportunity is particularly significant as it supports the VA's commitment to ensuring a reliable supply of essential medications for veterans while promoting small business participation in federal contracting. Interested suppliers must submit their quotations, including a signed solicitation cover page, a completed price schedule, a valid State Wholesale Distributor License, and a Buy American Act certificate by September 17, 2024, at 3:00 PM Central Time. For further inquiries, vendors can contact Kelley Cunningham at Kelley.Cunningham@va.gov or call 913-684-0140.
    6505--Aspirin_Dipyridamole SA Capsules (VA-25-00011491)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting offers for the procurement of Aspirin 25MG/Dipyridamole 200MG Sustained Action Capsules under solicitation number VA-25-00011491. This procurement aims to ensure a reliable supply chain for pharmaceuticals critical to various governmental health agencies, including the Department of Defense and Indian Health Services, and requires offerors to submit pricing for a base year and four option years, along with a Cost Recovery Fee of 0.5%. Compliance with the Drug Supply Chain Security Act (DSCSA) and FDA manufacturing standards is mandatory, and contractors must adhere to stringent packaging and labeling guidelines while demonstrating past performance evaluations. Interested parties should contact Contract Specialist Youlanda Duggar at youlanda.duggar@va.gov for further details.
    6505--Omeprazole Dr Capsules- NAC Repack
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) National Acquisition Center is preparing to issue a Request for Proposal (RFP) 36E79725R0002 for the procurement of Omeprazole DR Capsules, aimed at supporting various health service agencies, including the VA, Bureau of Prisons, and others. This unrestricted procurement will award one contract per group, with a total contract duration of one year and the potential for four additional one-year option periods. The procurement is critical for ensuring a reliable supply of essential medications, with specific packaging requirements including safety caps and unique NDC numbers for the products. Interested offerors should note that the solicitation is expected to be released electronically on or around November 19, 2024, with a closing date of December 3, 2024. For further inquiries, interested parties can contact Teresa Hussain at teresa.hussain@va.gov or by phone at 708-786-5852.
    763-25-1-021-0001 -Lancaster CMOP ACAMPROSATE -(VA-25-00009224)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the procurement of Acamprosate CA 333MG EC Tablets under the RFQ 36C77025Q0016, specifically targeting small businesses through a total small business set-aside. The procurement requires compliance with various federal regulations, including pharmaceutical labeling, delivery conditions, and documentation of product suitability, ensuring that vendors provide products with a minimum expiration of one year from the delivery date. This procurement is crucial for maintaining the supply of essential medications for veterans, with bids due by November 6, 2024, at 4:00 PM CST, and interested vendors can contact Sarah Fry at sarah.fry2@va.gov for further information.